Products & Services
Clinical Trials
A robust, vaidated solution for ASL MRI quantification in clinical trials.
Quantified Imaging develops the most robust and comprehensive solution for ASL MRI quantification in clinical trials. Backed by 20 years of R&D at the Universities of Nottingham and Oxford, and deployed into the largest academic neuroimaging studies, our FDA-cleared solution, QASL, offers the following features:
Cerebral blood flow
Arterial transit time
Unrivalled Accuracy
QASL is based on stochastic Bayesian inference, which results in superior accuracy and noise rejection compared to alternatives.
FDA Cleared
QASL is FDA-cleared and DICOM compatible with PCASL product sequences on Siemens and GE HealthCare MRI units.
Data Harmonisation
QASL has an unmatched ability to correct for inter-scanner hardware and software differences that confound accurate perfusion measurement, increasing repeatability and generalisability of this biomarker.
QC fail: labelling
QC fail: motion
Quality Reporting
QASL automatically scores each acquisition on multiple criteria specific to ASL. These are collated into a single report with an overall recommendation, normative ranges, and explanations of what the root causes may be.
Poor labelling and patient motion detected by QASL’s quality reporting
Tabular FreeSurfer ROI reporting
QASL is FDA-cleared and DICOM compatible with PCASL product sequences on Siemens and GE HealthCare MRI units
Longitudinal monitoring
QASL Monitor (research prototype) is our solution developed for longitudinal perfusion assessment. It implements established best-practice, including constructing between-timepoint common templates
Lecanemab treatment monitoring using ASL MRI. Single-delay 3D ASL on GE Discovery MR750 3T.
CLINICAL EVIDENCE
Trusted by leading
researchers and clinicians
QASL has been validated in 500+ subjects an is used in patient care, clinical trials and research worldwide.
“We now include ASL as our first screen for dementia, even before blood tests”
Prof Gloria Chiang
Neuroradiologist, Weill Cornell Medicine